Download Citation
Article Source:
AKT Signaling as a Novel Factor Associated with In Vitro Resistance of Human AML to Gemtuzumab Ozogamicin
Rosen DB,
Harrington KH,
Cordeiro JA,
Leung LY,
Putta S,
et al.
(2013)
AKT Signaling as a Novel Factor Associated with In Vitro Resistance of Human AML to Gemtuzumab Ozogamicin.
PLOS ONE 8(1): e53518.
https://doi.org/10.1371/journal.pone.0053518